- Home
- WRBY vs VKTX Comparison
WRBY vs VKTX Comparison
Compare WRBY & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRBY
- VKTX
- Stock Information
- Founded
- WRBY 2010
- VKTX 2012
- Country
- WRBY United States
- VKTX United States
- Employees
- WRBY N/A
- VKTX N/A
- Industry
- WRBY Ophthalmic Goods
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- WRBY Health Care
- VKTX Health Care
- Exchange
- WRBY Nasdaq
- VKTX Nasdaq
- Market Cap
- WRBY 2.7B
- VKTX 2.8B
- IPO Year
- WRBY 2021
- VKTX 2015
- Fundamental
- Price
- WRBY $22.19
- VKTX $31.11
- Analyst Decision
- WRBY Buy
- VKTX Buy
- Analyst Count
- WRBY 16
- VKTX 12
- Target Price
- WRBY $23.33
- VKTX $84.00
- AVG Volume (30 Days)
- WRBY 1.9M
- VKTX 4.1M
- Earning Date
- WRBY 08-07-2025
- VKTX 07-23-2025
- Dividend Yield
- WRBY N/A
- VKTX N/A
- EPS Growth
- WRBY N/A
- VKTX N/A
- EPS
- WRBY N/A
- VKTX N/A
- Revenue
- WRBY $795,094,000.00
- VKTX N/A
- Revenue This Year
- WRBY $16.13
- VKTX N/A
- Revenue Next Year
- WRBY $13.87
- VKTX N/A
- P/E Ratio
- WRBY N/A
- VKTX N/A
- Revenue Growth
- WRBY 13.94
- VKTX N/A
- 52 Week Low
- WRBY $12.46
- VKTX $18.92
- 52 Week High
- WRBY $28.68
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- WRBY 57.54
- VKTX 64.49
- Support Level
- WRBY $21.13
- VKTX $29.76
- Resistance Level
- WRBY $22.72
- VKTX $31.57
- Average True Range (ATR)
- WRBY 0.84
- VKTX 1.79
- MACD
- WRBY -0.09
- VKTX 0.50
- Stochastic Oscillator
- WRBY 71.85
- VKTX 94.08
About WRBY Warby Parker Inc.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.